Vanguard Group Inc Elanco Animal Health Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 47,827,085 shares of ELAN stock, worth $834 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
47,827,085
Previous 48,323,246
1.03%
Holding current value
$834 Million
Previous $507 Million
34.6%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ELAN
# of Institutions
418Shares Held
487MCall Options Held
905KPut Options Held
1.43M-
Dodge & Cox San Francisco, CA82.9MShares$1.44 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$902 Million0.6% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$406 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$396 Million0.08% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.6MShares$341 Million0.18% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $8.26B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...